John Choi

John Choi

Fondateur chez
Phyto Partners LLC
Finance
Consumer Services
Health Technology

Profil

Dr. John Choi, MD PhD, is Founder & Managing Director at Pytho Partners.
Dr. Choi co-founded Pytho Partners in 2006.
Prior to this, he was a Principal at Venrock Associates, one of the most distinguished venture capital firms in the country.
During his tenure there, he focused on Venrock's biotechnology and medical device franchises, working actively with portfolio companies such as Altea Therapeutics, Coley Pharmaceuticals, Sirna Therapeutics, Celladon Corporation, and Princeton Lightwave.
Dr. Choi was also previously involved with investments in NanoGram Devices (acquired by Wilson Greatbatch), Targeted Genetics Corporation, and led the investment in Skinetics Biosciences (acquired by Sirna Therapeutics).
Prior to Venrock, Dr. Choi worked at the San Francisco offices of TVM, a European venture capital firm, evaluating life science investment opportunities.
Before this, he served as a Resident in the Departments of Internal Medicine and Genetics at Baylor College of Medicine.
He has a M.D.
from Cornell University Medical College, a Ph.D.
in Biophysics from Harvard University, and graduated summa cum laude with a B.S.
in Applied Math-Physics from Yale College.

Postes actifs de John Choi

SociétésPosteDébut
Fondateur 26/10/2009

Anciens postes connus de John Choi

SociétésPosteFin
Private Equity Investor 31/12/2005
Corporate Officer/Principal 31/12/2001
HUA MEDICINE (SHANGHAI) LTD. Fondateur -
Voir l'expérience en détail de John Choi

Formation de John Choi

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

18

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Finance

Consumer Services

Finance

Consumer Services

Consumer Services

Health Technology

Finance